Medtronic Submits IDE to FDA for U.S. Randomized Clinical Trial for Uncontrolled Hypertension Patients with Systolic Blood Pressure Between 140-160 mm

ABCDEFGHIJKLMNOPQRSTUVWXYZ




To view the detailed information, you need to SUBSCRIBE with us.

 screenshot